Cancer Diagnostics Market set to exceed USD 156 billion by 2024

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe.

Delaware, Selbyville - June 13, 2019 /MarketersMedia/ —

Cancer Diagnostics Market is set to exceed USD 156 billion by 2024; according to a new research report.
Increasing prevalence of cancer across the globe will be major driving factor for cancer diagnostics market. World Health Organization reported that cancer accounted for 8.8 million deaths in 2015 and was second leading cause of mortality. Unhealthy eating habits and changing lifestyle are further expected to boost prevalence in near future rendering significant positive impact on demand for better cancer diagnostic methods.

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe. Awareness and accessibility of cancer diagnostic products is lower in developing and underdeveloped regions. Private as well as government organizations are conducting awareness campaigns to educate people regarding the importance of early diagnosis. Such activities will influence industrial growth. For instance, Roche in partnership with China Cancer Rehabilitation Society (CCRS) conducted ‘Run for Her' campaign to raise awareness about mammography.

Request a sample of this premium report titled at https://www.marketstudyreport.com/request-a-sample/859978/?utm_source=MM-VHS

Recent technological advancements enabling quick and accurate diagnosis will propel cancer diagnostics market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth.

However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.

Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth. These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.

The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.

U.S. dominated cancer diagnostics market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. cancer diagnostics market growth over the forecast timeframe.

China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.

Request a discount on standard prices of this premium report titled at https://www.marketstudyreport.com/check-for-discount/859978/?utm_source=MM-VHS

Some of the key industry players operating in global cancer diagnostics market are Sienna Cancer Diagnostics, F. Hoffmann-La Roche, Becton, Dickinson and Company, C.R. Bard, Qiagen, Abbott Laboratories, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens AG, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Toshiba Medical Systems Corporation, Agilent Technologies, and Hologic. Industry players are trying to garner higher market share through various organic as well as inorganic growth strategies. The companies in the industry are further trying to develop cost-effective and accurate diagnostics methods to get a competitive edge.

Report Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Cancer diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Cancer type trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Cancer Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls & challenges

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By cancer type

3.4.3. By end-use

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2016

3.7.1. Business overview

3.7.2. Revenue analysis

3.7.3. Product landscape

3.7.4. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Cancer Diagnostics Market, By Application

4.1. Global cancer diagnostics market share, by application, 2016 & 2024

4.2. Tumor biomarkers tests

4.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3. Imaging

4.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.1. Ultrasound and Radiology

4.3.1.1.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.2. Mammography

4.3.1.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.3. MRI Scan

4.3.1.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.4. PET Scan

4.3.1.4.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.5. CT Scan

4.3.1.5.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.6. SPECT & Others

4.3.1.6.1. Market estimates and forecast, by region, 2013 - 2024

4.4. Biopsy

4.4.1. Market estimates and forecast, by region, 2013 - 2024

4.5. Liquid Biopsy

4.5.1. Market estimates and forecast, by region, 2013 - 2024

4.6. Immunohistochemistry

4.6.1. Market estimates and forecast, by region, 2013 - 2024

4.7. In Situ Hybridization

4.7.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. Cancer Diagnostics Market, By Cancer type

5.1. Global cancer diagnostics market share, by cancer type, 2016 & 2024

5.2. Bladder Cancer

5.2.1. Market estimates and forecast, by region, 2013 - 2024

5.3. Breast Cancer

5.3.1. Market estimates and forecast, by region, 2013 - 2024

5.4. Colon and Rectal Cancer

5.4.1. Market estimates and forecast, by region, 2013 - 2024

5.5. Endometrial Cancer

5.5.1. Market estimates and forecast, by region, 2013 - 2024

5.6. Kidney Cancer

5.6.1. Market estimates and forecast, by region, 2013 - 2024

5.7. Leukemia

5.7.1. Market estimates and forecast, by region, 2013 - 2024

5.8. Liver-Lung Cancer

5.8.1. Market estimates and forecast, by region, 2013 - 2024

5.9. Melanoma

5.9.1. Market estimates and forecast, by region, 2013 - 2024

5.10. Non-Hodgkin Lymphoma

5.10.1. Market estimates and forecast, by region, 2013 - 2024

5.11. Pancreatic Cancer

5.11.1. Market estimates and forecast, by region, 2013 - 2024

5.12. Prostate Cancer

5.12.1. Market estimates and forecast, by region, 2013 - 2024

5.13. Thyroid Cancer

5.13.1. Market estimates and forecast, by region, 2013 - 2024

5.14. Others

5.14.1. Market estimates and forecast, by region, 2013 - 2024

Complete report titled at https://www.marketstudyreport.com/reports/cancer-diagnostics-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com/

Source URL: https://marketersmedia.com/cancer-diagnostics-market-set-to-exceed-usd-156-billion-by-2024/523987

Source: MarketersMedia

Release ID: 523987

Recent News

Where have the wild birds gone? 3 billion fewer than 1970

Sep 23, 2019

WASHINGTON — A comprehensive study shows there are nearly 3 billion fewer wild birds in North America than in 1970. The new study finds that the bird population in the United States and Canada was probably around 10.1 billion nearly half a century ago and has dropped 29% to about 7.2 billion birds. Study lead author Kenneth Rosenberg, a Cornell University conservation scientist, says the thinning of the flocks is happening before our eyes but is so slow we don't often notice. Rosenberg and colleagues projected population data using weather radar, which captures flocks of migrating birds, 13 different bird...

No Deal: Auto workers strike against GM in contract dispute

Sep 23, 2019

DETROIT — More than 49,000 members of the United Auto Workers walked off General Motors factory floors or set up picket lines early Monday as contract talks with the company deteriorated into a strike. Workers shut down 33 manufacturing plants in nine states across the U.S., as well as 22 parts distribution warehouses. It wasn't clear how long the walkout would last, with the union saying GM has budged little in months of talks while GM said it made substantial offers including higher wages and factory investments. It's the first national strike by the union since a two-day walkout in...

Union votes to strike at General Motors' US plants

Sep 23, 2019

DETROIT — The United Auto Workers union announced Sunday that its roughly 49,000 workers at General Motors plants in the U.S. would go on strike just before midnight because contentious talks on a new contract had broken down. About 200 plant-level union leaders voted unanimously in favor of a walkout during a meeting Sunday morning in Detroit. Union leaders said the sides were still far apart on several major issues and they apparently weren't swayed by a GM offer to make new products at or near two of the four plants it had been planning to close, according to someone...

Pesticide criticized in bee deaths could also kill birds

Sep 23, 2019

PORTLAND, Maine — Scientists studying a widely used pesticide say even small doses of the chemical can have crippling health effects on migrating birds, and it might be contributing to declines in their overall populations. The researchers with the University of Saskatchewan will publish their research about the insect-killer imidacloprid in the journal Science on Friday. The insecticide is among a class called neonicotinoids that has been widely studied for its health impacts on bees. The scientists studied white-crowned sparrows that consumed small doses of the pesticide and found that the birds experienced weight loss and delays in migration. They...

Apple takes on Netflix with a $5-a-month streaming service

Sep 23, 2019

CUPERTINO, Calif. — Apple is finally taking on Netflix with its own streaming television service and, uncharacteristically for the company, offering it at a bargain price — $5 a month beginning on Nov. 1. Walt Disney Co. is launching its own assault on Netflix the same month, for just $7. It may be sheer coincidence that the cost of paying for both Apple and Disney subscriptions will still be a dollar less than Netflix's main plan, priced at $13 a month. But the intent to disrupt Netflix's huge lead in the streaming business couldn't be clearer. Apple delivered the news...

About Us

Science Buzz is a user-friendly website which concentrates on news for the Big Three: Biology, Chemistry, and Physics.

Contact us: sales@thescnbuzz.com